Substituted alkanoic acids

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S375000, C548S222000, C546S198000

Reexamination Certificate

active

10427598

ABSTRACT:
The invention is directed to physiologically active compounds of general formula (I):wherein:represents (i) a saturated 3 to 6 membered carbocycle, optionally substituted by one or more alkyl groups, (ii) indanyl or (iii) a saturated 4 to 6 membered heterocyclic ring;R1represents R3Z1-Het- or R4N(R5)—C(═O)—NH—Ar1—;L1represents an —R6—R7— linkage;R2represents hydrogen, halogen, lower alkyl or lower alkoxy;L2represents an alkylene linkage;Y is carboxy or an acid bioisostere;and their corresponding N-oxides or prodrugs, and pharmaceutically acceptable salts and solvates of such compounds and their corresponding N-oxides or prodrugs.Such compounds have valuable pharmaceutical properties, in particular the ability to regulate the interaction of VCAM-1 and fibronectin with the integrin VLA-4 (α4β1).

REFERENCES:
patent: WO 99/33789 (1999-07-01), None
patent: WO 00/15612 (2000-03-01), None
patent: WO 02/36553 (2002-05-01), None

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Substituted alkanoic acids does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted alkanoic acids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted alkanoic acids will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3811051

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.